// App-Quantinova.ai

e16001 : Adjuvant chemotherapy for bladder cancer: A detailed characterization of factors precluding utilization.

Researchers

Presenter

  • Brian Robin Hu

Principal Investigators

  • Ian Roy

  • Hooman Djaladat

  • Anne K. Schuckman

  • Gus Miranda

  • Tanya B. Dorff

  • David I. Quinn

  • Siamak Daneshmand

Medical Centers

  • Loma Linda University, Redlands, CA

  • University of Southern California, Los Angeles, CA

  • University of Southern California, Institute of Urology, Los Angeles, CA

  • Institute of Urology, University of Southern California, Los Angeles, CA

  • Keck School of Medicine of University of Southern California, Los Angeles, CA

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final